VERU INC. Cash Provided by (Used in) Operating Activities, Discontinued Operations
VERU INC. (VERU) reported Cash Provided by (Used in) Operating Activities, Discontinued Operations of $0 for the 9-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Operating Activities
us-gaap:CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations · last filed 2026-08-10
- VERU INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2026-06-30 was $0.00.
- VERU INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2026-03-31 was $0.00.
- VERU INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-12-31 was $0.00.
- VERU INC. cash provided by (used in) operating activities, discontinued operations for the quarter ending 2025-06-30 was -$565.00.
| Period end | Cash Provided by (Used in) Operating Activities, Discontinued Operations 3 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 6 month | Cash Provided by (Used in) Operating Activities, Discontinued Operations 9 month |
|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-10 | $0.00 10-Q · filed 2026-08-10 |
| 2026-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | $0.00 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $0.00 10-Q · filed 2026-02-11 | ||
| 2025-06-30 | -$565.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2026-08-10 | -$9.97K derived: sum of 2 quarters · filed 2026-08-10 | -$335.43K 10-Q · filed 2026-08-10 |
| 2025-03-31 | -$9.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-05-13 | -$334.86K 10-Q · filed 2026-05-13 | |
| 2024-12-31 | -$325.45K 10-Q · filed 2026-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |